In patients with FMF, it significantly reduces circulating endothelial markers like asymmetric dimethylarginine (ADMA), thrombomodulin (TM), and osteoprotegerin (OPG), clearly reflecting its endothelial protective properties [37]. Here, TNFRSF11B is linked to familial Mediterranean fever.